Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: Aqueous drug absorption and prostaglandin E2 levels
Authors:
- 1 September 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 34 (9) , 1509-1512
Abstract
To compare aqueous drug concentrations and prostaglandin E(2) (PGE(2)) levels in patients treated with ketorolac 0.4% and bromfenac 0.09% at trough dosing. Private practice, Wilkes-Barre, Pennsylvania, USA. This single-center randomized investigator-masked clinical study comprised 56 patients having cataract surgery. Patients received 1 drop of ketorolac 0.4% or bromfenac 0.09% 6 hours and 12 hours preoperatively consistent with on-label dosing schedules. Aqueous humor was collected at the start of surgery and analyzed for concentrations of ketorolac and bromfenac using a reverse-phase high-performance liquid chromatography-mass spectroscopy system and for PGE(2) levels by competitive enzyme immunoassay. The mean aqueous PGE(2) level was 204.2 pg/mL +/- 95.5 (SD) in patients treated with ketorolac 0.4% and 263.7 +/- 90.0 pg/mL in patients treated with bromfenac 0.09%, (P = .020). The mean aqueous concentration of ketorolac and bromfenac at trough dosing was 130.5 +/- 37.8 ng/mL and 6.2 +/- 3.1 ng/mL, respectively (P = .004). Higher aqueous levels and greater PGE(2) inhibition were observed in cataract surgery patients treated with ketorolac 0.4% than in patients treated with bromfenac 0.09% at trough dosing. These findings suggest that ketorolac 0.4% administered 4 times a day may provide better control of prostaglandin-mediated inflammation than bromfenac 0.09% administered twice a day.Keywords
This publication has 13 references indexed in Scilit:
- Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and InflammationOphthalmology, 2007
- The Role of NSAIDs in the Management of Postoperative Ophthalmic InflammationDrugs, 2007
- Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: Pharmacokinetic-response curveJournal of Cataract & Refractive Surgery, 2006
- Evaluation of 0.4% Ketorolac Tromethamine Ophthalmic Solution Versus 0.5% Ketorolac Tromethamine Ophthalmic Solution After Phacoemulsification and Intraocular Lens ImplantationJournal of Ocular Pharmacology and Therapeutics, 2006
- An update on the use of ophthalmic ketorolac tromethamine 0.4%Expert Opinion on Pharmacotherapy, 2005
- Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgeryCurrent Medical Research and Opinion, 2004
- Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patientsJournal of Cataract & Refractive Surgery, 2004
- Control of intraocular inflammation associated with cataract surgeryCurrent Opinion in Ophthalmology, 2000
- Cystoid macular edema following cataract surgeryCurrent Opinion in Ophthalmology, 2000
- The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.British Journal of Ophthalmology, 1996